Cubist Systematic Strategies’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Cubist Systematic Strategies’s Portfolio WX Stock Details WX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,012	Closed	-$233K	–	2251
2015 Q1	$233K	Sell	6,012 -21,679	-78%	-$835K	0.01%	1429
2014 Q4	$932K	Buy	27,691 +5,841	+27%	+$206K	0.05%	542
2014 Q3	$765K	Sell	21,850 -31,779	-59%	-$1.09M	0.05%	589
2014 Q2	$1.76M	Buy	+53,629	New	+$1.84M	0.11%	270

Other funds holding WX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CGI

Comgest Global Investors Paris, France $4.59B AUM 12.96% 1-Year Est. Return

ACM

Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return

Cubist Systematic Strategies's WX Position: Q2 2015 in Review

Cubist Systematic Strategies sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q2 2015, closing a stake of 6,012 shares — an estimated $233K sold.

Cubist Systematic Strategies first reported a position in WX in Q2 2014 and held it in 4 quarters. The position peaked at $1.76M in Q2 2014. 154 funds tracked by Wall St. Rank hold WX as of Q2 2015.

Cubist Systematic Strategies reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q2 2015 after selling out during the quarter.
Cubist Systematic Strategies sold 6,012 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q2 2015, an estimated $233K.
Cubist Systematic Strategies first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2014 and held it in 4 quarters.
Cubist Systematic Strategies's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $1.76M in Q2 2014.
154 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q2 2015.

Based on Cubist Systematic Strategies's 13F filing for Q2 2015, filed 14 Aug 2015.